Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sofamor tops $100 million this quarter:

This article was originally published in Clinica

Executive Summary

Memphis, Tennessee-based Sofamor Danek's three-month sales topped $100 million for the first time in the company's history. The orthopaedics company says domestic sales growth was led mainly by an increase in the number of instrumented spinal fusions. During the third quarter, the FDA issued a final rule reclassifying pedicle screw systems, after over three years of review. The company says the ruling is a "real victory" for the spinal implant industry and should hasten the end of Sofamor's pedicle screw-related litigation.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts